Cargando…
Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study
BACKGROUND: Despite aggressive treatment regimens comprising surgery and radiochemotherapy, glioblastoma (GBM) remains a cancer entity with very poor prognosis. The development of novel, combined modality approaches necessitates adequate preclinical model systems and therapy regimens that closely re...
Autores principales: | Stegen, Benjamin, Nieto, Alexander, Albrecht, Valerie, Maas, Jessica, Orth, Michael, Neumaier, Klement, Reinhardt, Sabine, Weick-Kleemann, Moritz, Goetz, Wilfried, Reinhart, Merle, Parodi, Katia, Belka, Claus, Niyazi, Maximilian, Lauber, Kirsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977274/ https://www.ncbi.nlm.nih.gov/pubmed/31969174 http://dx.doi.org/10.1186/s13014-020-1470-2 |
Ejemplares similares
-
Investigation of the usability of conebeam CT data sets for dose calculation
por: Richter, Anne, et al.
Publicado: (2008) -
Flat-panel conebeam CT in the clinic: history and current state
por: Fahrig, Rebecca, et al.
Publicado: (2021) -
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond
por: Orth, Michael, et al.
Publicado: (2021) -
Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer
por: de Jong, Rianne, et al.
Publicado: (2021) -
Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy
por: Schnöller, Leon Emanuel, et al.
Publicado: (2022)